Crown (NYSE:CCK) Price Target Raised to $145.00

Crown (NYSE:CCK) had its price objective hoisted by research analysts at Bank of America from $129.00 to $145.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the industrial products company’s stock. Bank of America‘s price objective would indicate a potential upside of 32.16% from the company’s previous close.

A number of other research firms have also recently commented on CCK. Royal Bank Of Canada boosted their price target on shares of Crown from $129.00 to $131.00 and gave the stock an “outperform” rating in a research note on Thursday. UBS Group dropped their price objective on shares of Crown from $120.00 to $112.00 and set a “neutral” rating for the company in a report on Wednesday, April 29th. Wells Fargo & Company cut their target price on shares of Crown from $111.00 to $109.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Truist Financial reduced their target price on Crown from $135.00 to $129.00 and set a “buy” rating on the stock in a research note on Wednesday, April 15th. Finally, JPMorgan Chase & Co. upgraded Crown from a “neutral” rating to an “overweight” rating and set a $107.00 price target on the stock in a research report on Monday, May 18th. Twelve investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Crown has an average rating of “Moderate Buy” and an average price target of $121.64.

Crown Price Performance

NYSE:CCK traded down $0.03 during trading hours on Tuesday, hitting $109.71. 71,519 shares of the company’s stock traded hands, compared to its average volume of 1,142,685. The firm has a market cap of $12.26 billion, a P/E ratio of 17.48, a P/E/G ratio of 1.84 and a beta of 0.60. Crown has a 52 week low of $89.21 and a 52 week high of $116.62. The business’s fifty day simple moving average is $101.83 and its two-hundred day simple moving average is $104.42. The company has a quick ratio of 0.70, a current ratio of 1.12 and a debt-to-equity ratio of 1.67.

Crown (NYSE:CCK) last posted its earnings results on Monday, April 27th. The industrial products company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.75 by $0.11. The business had revenue of $3.26 billion during the quarter, compared to analysts’ expectations of $3.03 billion. Crown had a return on equity of 26.62% and a net margin of 5.65%.The firm’s revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.67 earnings per share. Crown has set its FY 2026 guidance at 7.900-8.300 EPS and its Q2 2026 guidance at 2.100-2.200 EPS. On average, research analysts anticipate that Crown will post 8.05 earnings per share for the current fiscal year.

Insider Buying and Selling at Crown

In other news, CEO Timothy J. Donahue sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 23rd. The shares were sold at an average price of $105.00, for a total value of $1,575,000.00. Following the completion of the sale, the chief executive officer directly owned 436,070 shares in the company, valued at approximately $45,787,350. The trade was a 3.33% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Crown

A number of large investors have recently added to or reduced their stakes in CCK. Caitong International Asset Management Co. Ltd purchased a new position in shares of Crown in the third quarter worth about $29,000. ORG Partners LLC increased its stake in Crown by 52.5% in the 4th quarter. ORG Partners LLC now owns 305 shares of the industrial products company’s stock worth $31,000 after purchasing an additional 105 shares during the period. Geneos Wealth Management Inc. lifted its position in Crown by 45.3% in the first quarter. Geneos Wealth Management Inc. now owns 356 shares of the industrial products company’s stock valued at $32,000 after purchasing an additional 111 shares during the last quarter. BOK Financial Private Wealth Inc. purchased a new stake in shares of Crown during the fourth quarter valued at approximately $42,000. Finally, Smartleaf Asset Management LLC boosted its stake in shares of Crown by 52.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 440 shares of the industrial products company’s stock valued at $46,000 after purchasing an additional 151 shares during the period. Hedge funds and other institutional investors own 90.93% of the company’s stock.

About Crown

Crown Holdings, Inc is a leading global supplier of rigid packaging products for consumer goods markets. The company designs, manufactures and sells metal packaging for beverage, food, household, personal care and specialty products. Its portfolio includes aluminum and steel beverage cans, steel food cans, aluminum aerosols, metal closures and ends, offering customers end-to-end solutions from design and prototyping to large-scale production.

Founded in 1919 as the Crown Cork & Seal Company, Crown has grown through strategic acquisitions and investments in advanced manufacturing technologies.